Home / CREO.L : LSE

AI Analysis Fundamentals Video Analysis Similar

AI Analysis

How does CREO.L make money? Does CREO.L have pricing power? What's the Earnings Whisper? Will CREO.L profit more as the business scales? What is CREO.L's management track record? Is CREO.L's current price justified?

Creo Medical Limited

12.3p +$2.15 (+21.18%)

LSE · 16 Sep 2026 13:00 UTC

Previous Close

12.38p

Day Range

12.25p12.5p

Year Range

9.52p18.5p

Market Cap

59.75M

AVG Volume

656.88K

Trailing/Forward PE

9.76/-

PEG ratio

-0.24

Dividend Yield

Next Earnings Date

2026-09-30

Primary Exchange

London Stock Exchange

Revenue (GBP)

CREO.L Revenue (GBP) by quarter
Period	Revenue (GBP)
25 Q4	3.8M
25 Q2	2.2M
24 Q2	15.2M
23 Q4	15.1M
23 Q2	15.7M
22 Q4	13.53M
22 Q2	13.64M
21 Q4	12.26M
21 Q2	12.9M
20 Q4	9.43M

Net Income (GBP)

CREO.L Net Income (GBP) by quarter
Period	Net Income (GBP)
25 Q4	-11.6M
25 Q2	16.9M
24 Q2	-12.3M
23 Q4	-10.1M
23 Q2	-11.6M
22 Q4	-13.5M
22 Q2	-13.43M
21 Q4	-14.7M
21 Q2	-9.9M
20 Q4	-11.27M

Operating Income (GBP)

CREO.L Operating Income (GBP) by quarter
Period	Operating Income (GBP)
25 Q4	-10.7M
25 Q2	-10M
24 Q2	-13.7M
23 Q4	-11.8M
23 Q2	-13.4M
22 Q4	-14.85M
22 Q2	-15.96M
21 Q4	-18.89M
21 Q2	-11.06M
20 Q4	-12.89M

EBITDA (GBP)

CREO.L EBITDA (GBP) by quarter
Period	EBITDA (GBP)
25 Q4	-10.2M
25 Q2	-9.5M
24 Q2	-11.8M
23 Q4	-9.3M
23 Q2	-11.4M
22 Q4	-13.11M
22 Q2	-14.47M
21 Q4	-17.48M
21 Q2	-9.86M
20 Q4	-11.63M

Cash Flows (GBP)

CREO.L Cash Flows (GBP) by quarter
Period	Cash Flows (GBP)
25 Q4	-34.2M
25 Q2	15.3M
24 Q4	0
24 Q2	-14.2M
23 Q4	-7.2M
23 Q2	-15.4M
22 Q4	-10.51M
22 Q2	-17.75M
21 Q4	-18.93M
21 Q2	-13.17M

EPS (GBP)

CREO.L EPS (GBP) by quarter
Period	EPS (GBP)
25 Q4	-0.03
25 Q2	0.04
24 Q2	-0.03
23 Q4	-0.03
23 Q2	-0.04
22 Q4	-0.07
22 Q2	-0.07
21 Q4	-0.08
21 Q2	-0.06
20 Q4	-0.07

Expenses (GBP)

CREO.L Expenses (GBP) by quarter
Period	Expenses (GBP)
24 Q4	0
25 Q4	11.6M
25 Q2	11M
24 Q2	21.3M
23 Q4	32.3M
23 Q2	19.7M
22 Q4	21.09M
22 Q2	23M
21 Q4	28.6M
21 Q2	16.5M
20 Q4	15.73M

Cash & Debt (GBP)

CREO.L Cash & Debt (GBP) by quarter
Period	Cash & Debt (GBP)
25 Q4	12.4M
25 Q2	20.5M
24 Q4	8.7M
24 Q2	9.8M
23 Q4	18.5M
23 Q2	26.5M
22 Q4	13.1M
22 Q2	26.1M
21 Q4	43.53M
21 Q2	30.55M

Debt ratios

CREO.L Debt ratios by quarter
Period	Debt ratios
24 Q2	-0.1
23 Q4	0.21
23 Q2	0.31
22 Q4	0.05
22 Q2	0.29
21 Q4	0.67
21 Q2	0.53
20 Q4	0.82
20 Q2	2.01
19 Q4	2.97

Margins

CREO.L Margins by quarter
Period	Margins
25 Q4	23.68%
25 Q2	45.45%
24 Q2	47.37%
23 Q4	51.66%
23 Q2	36.94%
22 Q4	36.24%
22 Q2	37.45%
21 Q4	33.39%
21 Q2	38.21%
20 Q4	30.09%

Return on Capital

CREO.L Return on Capital by quarter
Period	Return on Capital
25 Q4	-23.2%
25 Q2	27.75%
24 Q2	-25.95%
23 Q4	-16.89%
23 Q2	-16.81%
22 Q4	-27.33%
22 Q2	-21.99%
21 Q4	-20.05%
21 Q2	-18.94%
20 Q4	-17.94%

Shares Outstanding

CREO.L Shares Outstanding by quarter
Period	Shares Outstanding
25 Q4	412.81M
25 Q2	415.64M
24 Q2	361.67M
23 Q4	359.53M
23 Q2	266.48M
22 Q4	187.94M
22 Q2	187.85M
21 Q4	175.26M
21 Q2	163.76M
20 Q4	163.75M

Book Value Per Share (GBP)

CREO.L Book Value Per Share (GBP) by quarter
Period	Book Value Per Share (GBP)
25 Q4	0.12
25 Q2	0.15
24 Q2	0.13
23 Q4	0.17
23 Q2	0.26
22 Q4	0.26
22 Q2	0.33
21 Q4	0.42
21 Q2	0.32
20 Q4	0.38

Total Assets (GBP)

CREO.L Total Assets (GBP) by quarter
Period	Total Assets (GBP)
25 Q4	59.1M
25 Q2	68.8M
24 Q4	65M
24 Q2	69.3M
23 Q4	76.6M
23 Q2	88.7M
22 Q4	75.34M
22 Q2	87.5M
21 Q4	100.61M
21 Q2	80.63M

No video analysis for this stock yet. Request one from our team.

AI Analysis

Creo Medical Limited

Video analysis: CREO.L

Similar companies